Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M316Revenue $M0.2Net Margin (%)0Z-Score-4.5
Enterprise Value $M222EPS $-1.3Operating Margin %0F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %0Quick Ratio3.5Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %0Current Ratio3.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-109.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-218.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M104ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with SNTA

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
SNTAJohn Burbank 2014-06-30 Sold Out -0.01%$3.97 - $4.48
$ 3.03-28%Sold Out0
SNTAJohn Burbank 2014-03-31 Buy 0.01%$4.28 - $7.01
$ 3.03-46%New holding, 46620 sh.46,620
SNTAJean-Marie Eveillard 2012-06-30 Sold Out -0.0035%$3.68 - $7.82
$ 3.03-35%Sold Out0
SNTAJean-Marie Eveillard 2012-03-31 Buy $4.22 - $5.66
$ 3.03-32%New holding, 200000 sh.200,000
SNTAMichael Price 2011-06-30 Sold Out -0.1%$4.45 - $6.23
$ 3.03-44%Sold Out0
SNTAMichael Price 2010-06-30 Buy 0.07%$2.67 - $4.79
$ 3.03-16%New holding, 118058 sh.118,058
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNTA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SNTA John Burbank 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!

SNTA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Kovner BruceDirector, 10% Owner 2014-09-30Buy300,000$3.08-1.62view
Kovner BruceDirector, 10% Owner 2014-04-11Buy1,250,000$4.01-24.44view
Bahcall Safi RPresident and CEO 2013-11-13Buy20,000$3.75-19.2view
REARDON WILLIAM SDirector 2013-11-13Buy13,333$3.75-19.2view
Gollust Keith RDirector 2013-11-13Buy150,000$3.75-19.2view
Kovner BruceDirector, 10% Owner 2013-11-13Buy5,000,000$3.75-19.2view
Bahcall Safi RPresident and CEO 2013-06-28Buy10,000$5.03-39.76view
Kovner BruceDirector, 10% Owner 2013-06-27Buy150,000$4.71-35.67view
Kovner BruceDirector, 10% Owner 2013-06-26Buy500,000$4.53-33.11view
Kovner BruceDirector, 10% Owner 2013-06-21Buy250,000$4.39-30.98view

Press Releases about SNTA :

    Quarterly/Annual Reports about SNTA:

    News about SNTA:

    Articles On GuruFocus.com
    Top 4 Insider Buys of Last Week Jun 10 2013 
    Weekly CEO Buys Highlight: SNTA, MEI, PZG, MCHX, CMXI Jul 07 2012 
    Weekly CEO Buys Highlight: SNTA, MEI, PZG, MCHX, CMXI Jul 07 2012 
    These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
    Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 5,000 Shares Mar 15 2011 
    Synta Pharmaceuticals Inc. (SNTA) VP, Fin. and Admin., CFO Keith S Ehrlich sells 2,537 Shares Mar 03 2011 
    Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares Jun 10 2010 
    Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 22,222 Shares Jan 12 2010 
    Synta Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2009 

    More From Other Websites
    Synta Reports Inducement Grant to New Chief Executive Officer Sep 04 2014
    SYNTA PHARMACEUTICALS CORP Financials Aug 15 2014
    SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Aug 06 2014
    Q2 2014 Synta Pharmaceuticals Corp Earnings Release - Before Market Open Aug 06 2014
    Synta Names Anne Whitaker Chief Executive Officer Aug 06 2014
    Synta Reports Second Quarter Financial Results and Provides Corporate Update Aug 06 2014
    SYNTA PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report Aug 06 2014
    Synta to Host Conference Call and Webcast of Second Quarter 2014 Financial Results on August 6, 2014 Jul 30 2014
    Synta Pharmaceuticals data positive, says JMP Securities Jul 22 2014
    SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 21 2014
    Synta Announces Advancement of Ganetespib into Phase 3 Extension of AML LI-1 Study for Patients with... Jul 21 2014
    SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 18 2014
    Synta Pharmaceuticals (SNTA) Shares March Higher, Can It Continue? Jul 08 2014
    Synta Pharmaceuticals (SNTA) Jumps: Stock Rises 7.9% Jul 07 2014
    SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers Jun 27 2014
    Synta Pharmaceuticals mentioned positively by The Street contributor Jun 24 2014
    A Beaten-Down Biotech Stock Gearing Up for a Big Squeeze Higher Jun 24 2014
    5-Star Biotech Stock Watch: Synta Pharmaceuticals Jun 18 2014
    SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 17 2014
    Why A Short Covering Rally Might Come for Synta (SNTA) Stock Jun 16 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial